Actin: A novel interaction partner of WT1 influencing its cell dynamic properties

Oncogene

Volumn 29, Issue 7, 2010, Pages 1085-1092

  Dudnakova, T ^a   Spraggon, L ^a,b   Slight, J ^a   Hastie, N ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Actin; Nucleo cytoplasmic shuttling; WT1

Indexed keywords

ACTIN; WT1 PROTEIN;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; POLYSOME; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; RAT;

ACTINS; ANIMALS; CELL LINE; CYTOPLASM; HUMANS; MICE; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; RATS; WT1 PROTEINS;

EID: 77149125917     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.444     Document Type: Article

References (22)

1. Bing Z, Pasha TL, Acs G, Zhang PJ. (2008). Cytoplasmic over-expression of WT-1 in gastrointestinal stromal tumor and other soft tissue tumors. Appl Immunohistochem Mol Morphol 16: 316-321.
2. Caricasole A, Duarte A, Larsson SH, Hastie ND, Little M, Holmes G et al. (1996). RNA binding by the Wilms tumor suppressor zinc finger proteins. Proc Natl Acad Sci USA 93: 7562-7566.
3. Davies RC, Calvio C, Bratt E, Larsson SH, Lamond AI, Hastie ND. (1998). WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceo-somes. Genes Dev 12: 3217-3225.
4. de Lanerolle P, Johnson T, Hofmann WA. (2005). Actin and myosin I in the nucleus: what next? Nat Struct Mol Biol 12: 742-746.
5. Review. Discenza MT, Dehbi M, Pelletier J. (1997). Overlapping DNA recognition motifs between Sp1 and a novel trans-acting factor within the wt1 tumour suppressor gene promoter. Nucleic Acids Res 25: 4314-4322.
6. Gabert J, Beillard E, van der Velden V, Bi W, Grimwade D, Pallisgaard N et al. (2003). Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-A Europe Against Cancer Program. Leukemia 17: 2318-2357. (Pubitemid 38072573)
7. Gimona M. (2008). The microfilament system in the formation of invasive adhesions. Semin Cancer Biol 18: 23-34.
8. Hohenstein P, Hastie ND. (2006). The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet 15(Spec No 2): R196-R201. Review.
9. Jansen RP. (1999). RNA-cytoskeletal associations. FASEB J 13: 455-466. Review.
10. Jomgeow T, Oji Y, Tsuji N, Ikeda Y, Ito K, Tsuda A et al. (2006). Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci 97: 259-270.
11. Ladomery MR, Slight J, Mc Ghee S, Hastie ND. (1999). Presence of WT1, the Wilm's tumor suppressor gene product, in nuclear poly(A)(+) ribonucleoprotein. J Biol Chem 274: 36520-36526.
12. Ladomery M, Sommerville J, Woolner S, Slight J, Hastie N. (2003). Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one. J Cell Sci 116(Pt 8): 1539-1549.
13. Lee SB, Huang K, Palmer R, Truong VB, Herzlinger D, Kolquist KA et al. (1999). The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell 98: 663-673.
14. Louvet E, Percipalle P. (2009). Transcriptional control of gene expression by actin and myosin. Int Rev Cell Mol Biol 272: 107-147.
15. Nakatsuka S, Oji Y, Horiuchi T, Kanda T, Kitagawa M, Takeuchi T et al. (2006). Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 19: 804-814.
16. Niksic M, Slight J, Sanford JR, Caceres JF, Hastie ND. (2004). The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum Mol Genet 13: 463-471.
17. Rao J, Li N. (2004). Microfilament actin remodeling as a potential target for cancer drug development. Curr Cancer Drug Targets 4: 345-354.
18. Sheikh S, Gratzer WB, Pinder JC, Nash GB. (1997). Actin polymerisation regulates integrin-mediated adhesion as well as rigidity of neutrophils. Biochem Biophys Res Commun 238: 910-915.
19. Spraggon L, Dudnakova T, Slight J, Lustig-Yariv O, Cotterell J, Hastie N et al. (2007). hnRNP-U directly interacts with WT1 and modulates WT1 transcriptional activation. Oncogene 26: 1484-1491.
20. Tellman G, Geulen O. (2006). LightCycler 480 Real-Time PCR System: innovative solutions for relative quantification. Biochemica 4: 16-18.
21. Vajjhala P, Macmillan E, Gonda T, Little M. (2003). The Wilms' tumour suppressor protein, WT1, undergoes CRM1-independent nucleocytoplasmic shuttling. FEBS Lett 554: 143-148.
22. Viney R, Morrison A, van den Heuvel L, Ni L, Mathieson P, Saleem M et al. (2007). A proteomic investigation of glomerular podocytes from a Denys-Drash Syndrome patient with a mutation in the Wilms tumour suppressor gene WT1. Proteomics 7: 804-815.